Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03663712 |
| Title | Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies (TEMPO) |
| Acronym | TEMPO |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Dan Blazer III, M.D. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Illinois College of Medicine at Chicago | Chicago | Illinois | 60612 | United States | Details | |
| Duke University Medical Center | Durham | North Carolina | 27710 | United States | Details | |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | 27013 | United States | Details |